A detailed history of Cibc Asset Management Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cibc Asset Management Inc holds 105,463 shares of TEVA stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
105,463
Previous 99,750 5.73%
Holding current value
$1.8 Million
Previous $1.62 Million 17.28%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$15.81 - $18.96 $90,322 - $108,318
5,713 Added 5.73%
105,463 $1.9 Million
Q2 2024

Aug 01, 2024

BUY
$12.78 - $17.4 $42,493 - $57,854
3,325 Added 3.45%
99,750 $1.62 Million
Q1 2024

May 09, 2024

SELL
$10.67 - $14.43 $17,146 - $23,189
-1,607 Reduced 1.64%
96,425 $1.36 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $48,898 - $64,013
-6,022 Reduced 5.79%
98,032 $1.02 Million
Q3 2023

Oct 30, 2023

SELL
$7.48 - $10.7 $1,825 - $2,610
-244 Reduced 0.23%
104,054 $1.06 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $7,114 - $9,675
-851 Reduced 0.81%
104,298 $923,000
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $49,274 - $58,757
-6,198 Reduced 5.57%
105,149 $958,000
Q3 2022

Nov 03, 2022

SELL
$6.86 - $11.95 $3,279 - $5,712
-478 Reduced 0.43%
111,347 $899,000
Q1 2022

May 06, 2022

BUY
$7.33 - $9.39 $36,452 - $46,696
4,973 Added 4.65%
111,825 $1.05 Million
Q4 2021

Feb 08, 2022

SELL
$7.9 - $10.19 $27,784 - $35,838
-3,517 Reduced 3.19%
106,852 $856,000
Q3 2021

Nov 09, 2021

BUY
$8.38 - $10.18 $42,335 - $51,429
5,052 Added 4.8%
110,369 $1.08 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $62,132 - $72,550
6,276 Added 6.34%
105,317 $1.04 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $88,582 - $109,743
8,567 Added 9.47%
99,041 $1.14 Million
Q4 2020

Feb 03, 2021

BUY
$8.61 - $11.04 $11,434 - $14,661
1,328 Added 1.49%
90,474 $873,000
Q3 2020

Nov 05, 2020

BUY
$8.57 - $12.69 $46,535 - $68,906
5,430 Added 6.49%
89,146 $803,000
Q2 2020

Jul 28, 2020

BUY
$8.12 - $13.12 $38,602 - $62,372
4,754 Added 6.02%
83,716 $1.03 Million
Q1 2020

Apr 30, 2020

BUY
$6.69 - $13.45 $12,128 - $24,384
1,813 Added 2.35%
78,962 $709,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $69,453 - $114,017
10,636 Added 15.99%
77,149 $756,000
Q3 2019

Oct 30, 2019

BUY
$6.16 - $9.6 $25,428 - $39,628
4,128 Added 6.62%
66,513 $458,000
Q2 2019

Aug 05, 2019

SELL
$8.12 - $15.72 $15,338 - $29,695
-1,889 Reduced 2.94%
62,385 $576,000
Q1 2019

May 06, 2019

BUY
$15.58 - $20.01 $24,631 - $31,635
1,581 Added 2.52%
64,274 $1.01 Million
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $75,474 - $123,324
5,173 Added 8.99%
62,693 $967,000
Q2 2018

Aug 09, 2018

BUY
$16.77 - $24.71 $28,207 - $41,562
1,682 Added 3.01%
57,520 $1.4 Million
Q1 2018

Apr 30, 2018

SELL
$16.68 - $22.07 $35,294 - $46,700
-2,116 Reduced 3.65%
55,838 $954,000
Q4 2017

Feb 02, 2018

SELL
$11.23 - $19.1 $87,324 - $148,521
-7,776 Reduced 11.83%
57,954 $1.1 Million
Q3 2017

Nov 06, 2017

BUY
$15.41 - $32.17 $1.01 Million - $2.11 Million
65,730
65,730 $1.16 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.